Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,630 | -11,985 | -6,137 | -34,515 | -28,193 |
| Depreciation Amortization | 1,325 | 860 | 431 | 1,451 | 1,097 |
| Other Working Capital | -122 | -796 | -888 | -1,448 | -1,957 |
| Other Operating Activity | 1,330 | 1,077 | 571 | 3,449 | 2,829 |
| Operating Cash Flow | $-15,097 | $-10,844 | $-6,023 | $-31,063 | $-26,224 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,132 | -1,080 | -3,345 | 37,766 | 39,890 |
| PPE Investments | 13 | 16 | -10 | -594 | -585 |
| Investing Cash Flow | $6,145 | $-1,064 | $-3,355 | $37,172 | $39,305 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -2,667 |
| Debt Repayment | -6,000 | -4,000 | -2,000 | -4,667 | N/A |
| Common Stock Issued | 9,331 | 7,453 | 1,381 | 429 | 42 |
| Financing Cash Flow | $3,331 | $3,453 | $-619 | $-4,238 | $-2,625 |
| Beginning Cash Position | 22,962 | 22,962 | 22,962 | 21,091 | 21,091 |
| End Cash Position | 17,341 | 14,507 | 12,965 | 22,962 | 31,547 |
| Net Cash Flow | $-5,621 | $-8,455 | $-9,997 | $1,871 | $10,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,097 | -10,844 | -6,023 | -31,063 | -26,224 |
| Capital Expenditure | -38 | -10 | -10 | -594 | -585 |
| Free Cash Flow | -15,135 | -10,854 | -6,033 | -31,657 | -26,809 |